List of articles in "Drug" category - Page 17

Erythromycin/sulfafurazole (trade name Pediazole) is a combination drug with the antibiotics erythromycin and sulfafurazole (the latter is also known as sulfisoxazole).It is indicated in acute otitis media in children particularly […]

PRL-8-53 is a nootropic research chemical derived from benzoic acid and phenylmethylamine (Benzylamine) that has been shown to act as a hypermnesic drug in humans; it was first synthesized by […]

Pembrolizumab (formerly lambrolizumab;also known as MK-3475) is a drug in development by Merck that targets the programmed cell death 1 (PD-1) receptor. The drug is intended for use in treating […]

The Heptavalent Botulism AntiToxin — HBAT made by Cangene Corporation — is a licensed commercially available botulism anti-toxin that effectively neutralizes all seven known botulinum nerve toxin serotypes (types A […]

AZD5423 is a phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary […]

LGX818 is a drug candidate for the treatment of melanoma with the V600E mutation in the B-RAF kinase. The substance is being developed by Novartis is in phase III clinical […]

New Phase I drug structure by Bristol-Myers Squibb disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat breast lung and colon cancers and leukemia. The […]

Sodelglitazar formerly known as GW 677954 is a thiazole PPARδ receptor agonist developed by GlaxoSmithKline. While it is primarily active at the PPARδ receptor it is considered a pan agonist […]

ADB-FUBINACA is a designer drug identified in synthetic cannabis blends in Japan in 2013. The (S) enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/106982 with a Ki value […]

ADBICA is a designer drug identified in synthetic cannabis blends in Japan in 2013. ADBICA had not previously been reported in the scientific literature prior to its sale as a […]